• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,847.57 -702.68
( -0.91%)
Global Indices
Nasdaq
48,558.84 319.59
(0.66%)
Dow Jones
6,987.77 80.53
(1.17%)
Hang Seng
57,815.15 1,312.38
(2.32%)
Nikkei 225
10,601.00 18.04
(0.17%)
Forex
USD-INR
93.15 0.65
(0.70%)
EUR-INR
109.13 1.08
(1.00%)
GBP-INR
125.28 1.20
(0.96%)
JPY-INR
0.58 0.00
(0.42%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5510998
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
22.22
103096.83
EPS(TTM)
Face Value()
Div & Yield %
55.59
1
0.65
 

biocon ltd
Info Edge (India) to pump Rs 30-cr in subsidiary, SIHL
Feb 18,2026
SIHL is engaged mainly in direct or indirect investments in tech companies and related activities including investment in Alternative Investment Funds (AIF). As of 31st March 2025, SIHL reported a profit of Rs 0.86 crore.

The fresh capital infusion will enable SIHL to explore investment opportunities including contribution to AIF(s) and other general purposes.

As a part of transaction, the company will acquire 14,01,214 compulsorily convertible debentures (CCDs) at an issue price of Rs 214.10 each including premium of Rs 114.10 per CCD. The said transaction will be completed within 30 days from the approval. Post this investment, SIHL remains the wholly owned subsidiary of the company.

Info Edge (India) is India's premier online classifieds company in recruitment, matrimony, real estate, education and related services.

The company reported a 23.11% jump in standalone net profit to Rs 246.45 crore on 13.85% increase in revenue from operations to Rs 764.55 crore in Q3 FY26 over Q3 FY25.

The counter declined 1.72% to Rs 1,111.15 on the BSE.